Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 5 (2020), Article ID 5:IJCPP-147, 4 pages
https://doi.org/10.15344/2456-3501/2020/147
Original Article
The Risk of Worsening Infections under Non-steroidal Anti-inflammatory: A French Observational Study

Quentin Jarrion*, François Krabansky, Brahim Azzouz, Aurore Morel and Thierry Trenque

Departement of Pharmacovigilance and Pharmacoepidemiology, Centre Hospitalier Universitaire de Reims, Reims, Champagne-Ardenne, FR 51092, France
Dr. Quentin Jarrion, Centre Régional de Pharmacovigilance et de Pharmacoépidémiologie de Champagne-Ardenne Centre Hospitalier Universitaire de Reims, Avenue du Général Koening, 51092 Reims Cedex, France, Tel: +33642777059, Fax : +33326832379; E-mail: quentinjarrion@yahoo.fr
26 March 2020; 26 May 2020; 28 May 2020
Jarrion Q, Krabansky F, Azzouz B, Morel A, Trenque T, et al. (2020) The Risk of Worsening Infections under Non-steroidal Anti-inflammatory: A French Observational Study. Int J Clin Pharmacol Pharmacother 5: 147. doi: https://doi.org/10.15344/2456-3501/2020/147
© 2020 Jarrion et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Anti-inflammatoires non stéroïdiens (AINS) et complications infectieuses graves - Point d’Information. [View]
  2. Leroy S, Marc E, Bavoux F, Tréluyer JM, Gendrel D, et al. (2010) Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs: A Prospective Adverse Drug Reaction Reporting Study. Clin Drug Invest 30: 179-185. [CrossRef] [Google Scholar] [PubMed]
  3. Duong M, Salvo F, Pariente A, Abouelfath A, Lassalle R, et al. (2014) Usage patterns of ‘over-the-counter’ vs . prescription-strength nonsteroidal anti-inflammatory drugs in France: Usage patterns of nonsteroidal anti-inflammatory drugs. Brit J Clin Pharmaco 77: 887-895. [CrossRef] [Google Scholar] [PubMed]
  4. Vane JR, Botting RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 2: 78-87. [CrossRef] [Google Scholar] [PubMed]
  5. Stevens DL (1995) Could Nonsteroidal Antiinflammatory Drugs (NSAIDs) Enhance the Progression of Bacterial Infections to Toxic Shock Syndrome? Clin Infect Dis 21: 977-980. [CrossRef] [Google Scholar] [PubMed]
  6. Hamilton SM, Bayer CR, Stevens DL, Bryant AE (2014) Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis. J Infect Dis 209: 1429-1435. [CrossRef] [Google Scholar] [PubMed]
  7. Solberg CO (1974) Influence of phenylbutazone on the phagocytic and bactericidal activities of neutrophil granulocytes. Acta Pathol Microbiol Scand B Microbiol Immunol 82: 258-262. [CrossRef] [Google Scholar] [PubMed]
  8. Kjosen B, Bassoe HH, Solberg CO (1976) Influence of phynylbutazone on leukocyte glucose metabolism and function. J Reticuloendothel Soc 20: 447-455. [Google Scholar] [PubMed]
  9. Solberg CO (1975) Influence of therapeutic concentrations of phenylbutazone on granulocyte function. Acta Pathol Microbiol Scand B 83: 100-102. [CrossRef] [Google Scholar] [PubMed]
  10. MacGregor RR, Spagnuolo PJ, Lentnek AL (1974) Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system. N Engl J Med 291: 642-646. [CrossRef] [Google Scholar] [PubMed]
  11. Kim JW (2008) [NSAID-induced gastroenteropathy]. Korean J Gastroenterol 52: 134-141. [Google Scholar] [PubMed]
  12. Vonkeman HE, van de Laar MAFJ (2010) Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention. Semin Arthritis Rheu 39: 294-312. [CrossRef] [Google Scholar] [PubMed]
  13. Smith RJ, Berk SL (1991) Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 84: 785-787. [CrossRef] [Google Scholar] [PubMed]
  14. Rietveld JA, Pilmore HL, Jones PG, Theis JC, Bowie DA, et al. (1995) Necrotising fasciitis: a single centre’s experience. NZ Med J 108: 72-74. [Google Scholar] [PubMed]
  15. Schwarz N, Redl H, Grasslober H, Krebitz B (2000) Necrotizing Soft Tissue Infection - An Increasing Problem in Orthopedic Trauma. Eur J Trauma 26: 62-68. [CrossRef] [Google Scholar]
  16. Kahn LH, Styrt BA (1997) Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 31: 1034-1039. [CrossRef] [Google Scholar] [PubMed]
  17. Forbes N, Rankin AP (2001) Necrotizing fasciitis and non steroidal anti-inflammatory drugs: a case series and review of the literature. N Z Med J 114: 3-6. [Google Scholar] [PubMed]
  18. Cisse M, Keïta M, Toure A, Camara A, Machet L, et al. (2007) Dermohypodermites bactériennes : étude monocentrique rétrospective de 244 cas observés en Guinée. Ann Dermatol Vener 134: 748-751. [CrossRef] [Google Scholar]
  19. Mikaeloff Y, Kezouh A, Suissa S (2008) Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Brit J Clin Pharmaco 65: 203-209. [CrossRef] [Google Scholar] [PubMed]
  20. Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, et al. (2016) Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study. J Pediatr 175: 47-53. [CrossRef] [Google Scholar] [PubMed]
  21. Souyri C, Olivier P, Grolleau S, Lapeyre-Mestre M, the French Network of Pharmacovigilance Centers, et al. (2008) Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol 33: 249-255. [CrossRef] [Google Scholar] [PubMed]
  22. Bennani-Baïti AA, Benbouzid A, Essakalli-Hossyni L (2015) Cervicofacial cellulitis: The impact of non-steroidal anti-inflammatory drugs. A study of 70 cases. Eur Ann Otorhinolaryngol Head Neck Dis 132: 181-184. [CrossRef] [Google Scholar] [PubMed]
  23. Louis ML, Launay F, Guillaume JM, Sabiani F, Chaumoître K, et al. (2006) Dermo-hypodermite nécrosante compliquant la varicelle chez l’enfant sous anti-inflammatoires non stéroïdiens. Rev Chir Orthop 92: 504-507. [CrossRef] [Google Scholar]
  24. Nicot R, Hippy C, Hochart C, Wiss A, Brygo A, et al. (2013) Les anti-inflammatoires aggravent-ils les cellulites faciales d’origine dentaire? Rev Stomatol Chir 114: 304-309. [CrossRef] [Google Scholar]
  25. Basille D, Plouvier N, Trouve C, Duhaut P, Andrejak C, et al. (2017) Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study. Lung 195: 201-208. [CrossRef] [Google Scholar] [PubMed]
  26. Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M, et al. (2011) Nonsteroidal Antiinflammatory Drugs May Affect the Presentation and Course of Community-Acquired Pneumonia. Chest 139: 387-394. [CrossRef] [Google Scholar] [PubMed]
  27. Messika J, Sztrymf B, Bertrand F, Dreyfuss D, Ricard JD, et al. (2010) Characteristics And Outcome Of Severe Pneumococcal Pneumonia In Patients Receiving Non-steroidal Anti Inflammatory Drugs Prior To Diagnosis. American Thoracic Society. [CrossRef] [Google Scholar]
  28. Le Turnier P, Boutoille D, Joyau C, Veyrac G, Asseray N, et al. (2017) Bacterial infections and NSAIDs exposure? Seek septic complications. Eur J Intern Med 41: 33-44. [CrossRef] [Google Scholar] [PubMed]
  29. Legras A, Giraudeau B, Jonville-Bera AP, Camus C, François B, et al. (2009) A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock. Crit Care 13: 43. [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.